is ozempic a glp-1 drug Another Weight-Loss Trial Win for Weekly Keeping the weight off following
Description
*FOR ORAL SEMAGLUTIDE USED FOR WEIGHT-LOSS SOURCE: New England Journal of Medicine
A meta-analysis [74] including the ELIXA [66], LEADER [44], SUSTAIN-6 [67], EXSCEL [68], REWIND [70], and AMPLITUDE-O [51] studies found that GLP-1RAs were associated with better renal outcomes: a 30% or 40% or more decrease in glomerular filtration rate, need for renal replacement therapy, end-stage renal failure, or death from kidney disease by 21%
J Diabetes Investig 2010;1:823.ArticlePubMedPMC 20
doi: 10.1111/dom.12247
Exenatide extended-release may cause small, persistent nodules at injection sites
